ID   BGLR_HUMAN              Reviewed;         651 AA.
AC   P08236; B4E1F6; E9PCV0; Q549U0; Q96CL9;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 2.
DT   10-MAY-2017, entry version 188.
DE   RecName: Full=Beta-glucuronidase;
DE            EC=3.2.1.31;
DE   AltName: Full=Beta-G1;
DE   Flags: Precursor;
GN   Name=GUSB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT PRO-649, AND
RP   ALTERNATIVE SPLICING.
RC   TISSUE=Placenta;
RX   PubMed=3468507; DOI=10.1073/pnas.84.3.685;
RA   Oshima A., Kyle J.W., Miller R.D., Hoffmann J.W., Powell P.P.,
RA   Grubb J.H., Sly W.S., Tropak M., Guise K.S., Gravel R.A.;
RT   "Cloning, sequencing, and expression of cDNA for human beta-
RT   glucuronidase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:685-689(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT
RP   PRO-649.
RC   TISSUE=Lung;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-70.
RX   PubMed=1916806; DOI=10.1016/0888-7543(91)90192-H;
RA   Shipley J.M., Miller R.D., Wu B.M., Grubb J.H., Christensen S.G.,
RA   Kyle J.W., Sly W.S.;
RT   "Analysis of the 5' flanking region of the human beta-glucuronidase
RT   gene.";
RL   Genomics 10:1009-1018(1991).
RN   [9]
RP   PROTEIN SEQUENCE OF 23-32 AND 160-175.
RC   TISSUE=Placenta;
RX   PubMed=1311180; DOI=10.1515/bchm3.1992.373.1.57;
RA   Tanaka J., Gasa S., Sakurada K., Miyazaki T., Kasai M., Makita A.;
RT   "Characterization of the subunits and sugar moiety of human placental
RT   and leukemic beta-glucuronidase.";
RL   Biol. Chem. Hoppe-Seyler 373:57-62(1992).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 520-585.
RC   TISSUE=Fibroblast;
RX   PubMed=3924735; DOI=10.1016/0378-1119(85)90300-2;
RA   Guise K.S., Korneluk R.G., Waye J., Lamhonwah A.-M., Quan F.,
RA   Palmer R., Ganschow R.E., Sly W.S., Gravel R.A.;
RT   "Isolation and expression in Escherichia coli of a cDNA clone encoding
RT   human beta-glucuronidase.";
RL   Gene 34:105-110(1985).
RN   [11]
RP   INHIBITION BY L-ASPARTIC ACID.
RX   PubMed=11568288; DOI=10.1203/00006450-200110000-00007;
RA   Kreamer B.L., Siegel F.L., Gourley G.R.;
RT   "A novel inhibitor of beta-glucuronidase: L-aspartic acid.";
RL   Pediatr. Res. 50:460-466(2001).
RN   [12]
RP   GLYCOSYLATION AT ASN-272.
RX   PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [13]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-272.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [14]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-173; ASN-272 AND ASN-631.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS).
RX   PubMed=8599764; DOI=10.1038/nsb0496-375;
RA   Jain S., Drendel W.B., Chen Z.W., Mathews F.S., Sly W.S., Grubb J.H.;
RT   "Structure of human beta-glucuronidase reveals candidate lysosomal
RT   targeting and active-site motifs.";
RL   Nat. Struct. Biol. 3:375-381(1996).
RN   [18]
RP   REVIEW ON VARIANTS.
RX   PubMed=19224584; DOI=10.1002/humu.20828;
RA   Tomatsu S., Montano A.M., Dung V.C., Grubb J.H., Sly W.S.;
RT   "Mutations and polymorphisms in GUSB gene in mucopolysaccharidosis VII
RT   (Sly Syndrome).";
RL   Hum. Mutat. 30:511-519(2009).
RN   [19]
RP   VARIANT MPS7 TRP-216.
RX   PubMed=8111412; DOI=10.1002/humu.1380020604;
RA   Vervoort R., Lissens W., Liebaers I.;
RT   "Molecular analysis of a patient with hydrops fetalis caused by beta-
RT   glucuronidase deficiency, and evidence for additional pseudogenes.";
RL   Hum. Mutat. 2:443-445(1993).
RN   [20]
RP   VARIANTS MPS7 VAL-354 AND TRP-611.
RX   PubMed=8111413; DOI=10.1002/humu.1380020605;
RA   Wu B.M., Sly W.S.;
RT   "Mutational studies in a patient with the hydrops fetalis form of
RT   mucopolysaccharidosis type VII.";
RL   Hum. Mutat. 2:446-457(1993).
RN   [21]
RP   VARIANTS MPS7 CYS-382 AND VAL-619.
RX   PubMed=1702266;
RA   Tomatsu S., Fukuda S., Sukegawa K., Ikedo Y., Yamada S., Yamada Y.,
RA   Sasaki T., Okamoto H., Kuwahara T., Yamaguchi S., Kiman T.,
RA   Shintaku H., Isshiki G., Orii T.;
RT   "Mucopolysaccharidosis type VII: characterization of mutations and
RT   molecular heterogeneity.";
RL   Am. J. Hum. Genet. 48:89-96(1991).
RN   [22]
RP   VARIANT MPS7 CYS-627.
RX   PubMed=7680524;
RA   Shipley J.M., Klinkenberg M., Wu B.M., Bachinsky D.R., Grubb J.H.,
RA   Sly W.S.;
RT   "Mutational analysis of a patient with mucopolysaccharidosis type VII,
RT   and identification of pseudogenes.";
RL   Am. J. Hum. Genet. 52:517-526(1993).
RN   [23]
RP   VARIANT MPS7 PHE-176, AND VARIANT PRO-649.
RX   PubMed=8089138;
RA   Wu B.M., Tomatsu S., Fukuda S., Sukegawa K., Orii T., Sly W.S.;
RT   "Overexpression rescues the mutant phenotype of L176F mutation causing
RT   beta-glucuronidase deficiency mucopolysaccharidosis in two Mennonite
RT   siblings.";
RL   J. Biol. Chem. 269:23681-23688(1994).
RN   [24]
RP   VARIANT MPS7 PHE-176, VARIANT ASN-152, AND CHARACTERIZATION OF VARIANT
RP   ASN-152.
RX   PubMed=7573038;
RA   Vervoort R., Islam M.R., Sly W., Chabas A., Wevers R., de Jong J.,
RA   Liebaers I., Lissens W.;
RT   "A pseudodeficiency allele (D152N) of the human beta-glucuronidase
RT   gene.";
RL   Am. J. Hum. Genet. 57:798-804(1995).
RN   [25]
RP   VARIANTS MPS7 SER-148 AND CYS-495.
RX   PubMed=7633414; DOI=10.1093/hmg/4.4.651;
RA   Yamada S., Tomatsu S., Sly W.S., Islam R., Wenger D.A., Fukuda S.,
RA   Sukegawa K., Orii T.;
RT   "Four novel mutations in mucopolysaccharidosis type VII including a
RT   unique base substitution in exon 10 of the beta-glucuronidase gene
RT   that creates a novel 5'-splice site.";
RL   Hum. Mol. Genet. 4:651-655(1995).
RN   [26]
RP   VARIANTS MPS7 ARG-136; LYS-150; PHE-176; TRP-216; CYS-320; SER-320;
RP   TYR-351; CYS-374; CYS-382; HIS-382; PRO-435; TRP-477; CYS-508;
RP   ASP-572; ASN-606 AND CYS-627.
RX   PubMed=8644704;
RA   Vervoort R., Islam M.R., Sly W.S., Zabot M.T., Kleijer W.J.,
RA   Chabas A., Fensom A., Young E.P., Liebaers I., Lissens W.;
RT   "Molecular analysis of patients with beta-glucuronidase deficiency
RT   presenting as hydrops fetalis or as early mucopolysaccharidosis VII.";
RL   Am. J. Hum. Genet. 58:457-471(1996).
RN   [27]
RP   VARIANTS MPS7 SER-408 AND LEU-415.
RX   PubMed=8707294; DOI=10.1007/s004390050207;
RA   Islam M.R., Vervoort R., Lissens W., Hoo J.J., Valentino L.A.,
RA   Sly W.S.;
RT   "beta-Glucuronidase P408S, P415L mutations: evidence that both
RT   mutations combine to produce an MPS VII allele in certain Mexican
RT   patients.";
RL   Hum. Genet. 98:281-284(1996).
RN   [28]
RP   VARIANT MPS7 PHE-52, AND CHARACTERIZATION OF VARIANT MPS7 PHE-52.
RX   PubMed=9099834; DOI=10.1007/s004390050389;
RA   Vervoort R., Buist N.R., Kleijer W.J., Wevers R., Fryns J.P.,
RA   Liebaers I., Lissens W.;
RT   "Molecular analysis of the beta-glucuronidase gene: novel mutations in
RT   mucopolysaccharidosis type VII and heterogeneity of the
RT   polyadenylation region.";
RL   Hum. Genet. 99:462-468(1997).
RN   [29]
RP   VARIANT ASN-152, AND VARIANTS MPS7 GLY-38 AND HIS-626.
RX   PubMed=9490302; DOI=10.1007/s004390050656;
RA   Vervoort R., Gitzelmann R., Bosshard N., Maire I., Liebaers I.,
RA   Lissens W.;
RT   "Low beta-glucuronidase enzyme activity and mutations in the human
RT   beta-glucuronidase gene in mild mucopolysaccharidosis type VII,
RT   pseudodeficiency and a heterozygote.";
RL   Hum. Genet. 102:69-78(1998).
RN   [30]
RP   VARIANT MPS7 PHE-176.
RX   PubMed=12859417; DOI=10.1034/j.1399-0004.2003.00119.x;
RA   Schwartz I., Silva L.R., Leistner S., Todeschini L.A., Burin M.G.,
RA   Pina-Neto J.M., Islam R.M., Shah G.N., Sly W.S., Giugliani R.;
RT   "Mucopolysaccharidosis VII: clinical, biochemical and molecular
RT   investigation of a Brazilian family.";
RL   Clin. Genet. 64:172-175(2003).
RN   [31]
RP   VARIANTS MPS7 ASN-350 AND LEU-577, AND CHARACTERIZATION OF VARIANT
RP   MPS7 ASN-350 LEU-577.
RX   PubMed=12522561; DOI=10.1007/s00439-002-0849-5;
RA   Storch S., Wittenstein B., Islam R., Ullrich K., Sly W.S., Braulke T.;
RT   "Mutational analysis in longest known survivor of
RT   mucopolysaccharidosis type VII.";
RL   Hum. Genet. 112:190-194(2003).
CC   -!- FUNCTION: Plays an important role in the degradation of dermatan
CC       and keratan sulfates.
CC   -!- CATALYTIC ACTIVITY: A beta-D-glucuronoside + H(2)O = D-glucuronate
CC       + an alcohol.
CC   -!- ENZYME REGULATION: Inhibited by L-aspartic acid.
CC   -!- SUBUNIT: Homotetramer.
CC   -!- SUBCELLULAR LOCATION: Lysosome.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Long;
CC         IsoId=P08236-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short;
CC         IsoId=P08236-2; Sequence=VSP_001799;
CC       Name=3;
CC         IsoId=P08236-3; Sequence=VSP_054830;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: N-linked glycosylated with 3 to 4 oligosaccharide chains.
CC       {ECO:0000269|PubMed:12754519, ECO:0000269|PubMed:16335952,
CC       ECO:0000269|PubMed:19159218}.
CC   -!- DISEASE: Mucopolysaccharidosis 7 (MPS7) [MIM:253220]: An autosomal
CC       recessive lysosomal storage disease characterized by inability to
CC       degrade glucuronic acid-containing glycosaminoglycans. The
CC       phenotype is highly variable, ranging from severe lethal hydrops
CC       fetalis to mild forms with survival into adulthood. Most patients
CC       with the intermediate phenotype show hepatomegaly, skeletal
CC       anomalies, coarse facies, and variable degrees of mental
CC       impairment. {ECO:0000269|PubMed:12522561,
CC       ECO:0000269|PubMed:12859417, ECO:0000269|PubMed:1702266,
CC       ECO:0000269|PubMed:7573038, ECO:0000269|PubMed:7633414,
CC       ECO:0000269|PubMed:7680524, ECO:0000269|PubMed:8089138,
CC       ECO:0000269|PubMed:8111412, ECO:0000269|PubMed:8111413,
CC       ECO:0000269|PubMed:8644704, ECO:0000269|PubMed:8707294,
CC       ECO:0000269|PubMed:9099834, ECO:0000269|PubMed:9490302}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 2 family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M15182; AAA52561.1; -; mRNA.
DR   EMBL; AK303819; BAG64768.1; -; mRNA.
DR   EMBL; AK223406; BAD97126.1; -; mRNA.
DR   EMBL; AC073261; AAQ96851.1; -; Genomic_DNA.
DR   EMBL; CH236961; EAL23740.1; -; Genomic_DNA.
DR   EMBL; CH471140; EAX07951.1; -; Genomic_DNA.
DR   EMBL; BC014142; AAH14142.1; -; mRNA.
DR   EMBL; M65002; AAA52622.1; -; Genomic_DNA.
DR   EMBL; M10618; AAA52621.1; -; mRNA.
DR   EMBL; S72462; AAD14101.1; -; Genomic_DNA.
DR   CCDS; CCDS5530.1; -. [P08236-1]
DR   CCDS; CCDS64665.1; -. [P08236-3]
DR   PIR; A26581; A26581.
DR   RefSeq; NP_000172.2; NM_000181.3. [P08236-1]
DR   RefSeq; NP_001271219.1; NM_001284290.1. [P08236-3]
DR   RefSeq; NP_001280033.1; NM_001293104.1.
DR   RefSeq; NP_001280034.1; NM_001293105.1.
DR   RefSeq; XP_005250354.1; XM_005250297.3. [P08236-2]
DR   UniGene; Hs.255230; -.
DR   PDB; 1BHG; X-ray; 2.53 A; A/B=21-633.
DR   PDB; 3HN3; X-ray; 1.70 A; A/B/D/E=21-633.
DR   PDBsum; 1BHG; -.
DR   PDBsum; 3HN3; -.
DR   ProteinModelPortal; P08236; -.
DR   SMR; P08236; -.
DR   BioGrid; 109245; 10.
DR   DIP; DIP-29724N; -.
DR   IntAct; P08236; 3.
DR   MINT; MINT-4054501; -.
DR   STRING; 9606.ENSP00000302728; -.
DR   BindingDB; P08236; -.
DR   ChEMBL; CHEMBL2728; -.
DR   CAZy; GH2; Glycoside Hydrolase Family 2.
DR   iPTMnet; P08236; -.
DR   PhosphoSitePlus; P08236; -.
DR   BioMuta; GUSB; -.
DR   DMDM; 146345377; -.
DR   EPD; P08236; -.
DR   MaxQB; P08236; -.
DR   PaxDb; P08236; -.
DR   PeptideAtlas; P08236; -.
DR   PRIDE; P08236; -.
DR   DNASU; 2990; -.
DR   Ensembl; ENST00000304895; ENSP00000302728; ENSG00000169919. [P08236-1]
DR   Ensembl; ENST00000421103; ENSP00000391390; ENSG00000169919. [P08236-3]
DR   GeneID; 2990; -.
DR   KEGG; hsa:2990; -.
DR   UCSC; uc003tun.4; human. [P08236-1]
DR   CTD; 2990; -.
DR   DisGeNET; 2990; -.
DR   GeneCards; GUSB; -.
DR   H-InvDB; HIX0057492; -.
DR   HGNC; HGNC:4696; GUSB.
DR   HPA; HPA036322; -.
DR   HPA; HPA036323; -.
DR   MalaCards; GUSB; -.
DR   MIM; 253220; phenotype.
DR   MIM; 611499; gene.
DR   neXtProt; NX_P08236; -.
DR   OpenTargets; ENSG00000169919; -.
DR   Orphanet; 584; Mucopolysaccharidosis type 7.
DR   PharmGKB; PA29075; -.
DR   eggNOG; KOG2024; Eukaryota.
DR   eggNOG; COG3250; LUCA.
DR   GeneTree; ENSGT00390000001752; -.
DR   HOGENOM; HOG000120896; -.
DR   HOVERGEN; HBG004843; -.
DR   InParanoid; P08236; -.
DR   KO; K01195; -.
DR   OMA; INFDFFN; -.
DR   OrthoDB; EOG091G02MO; -.
DR   PhylomeDB; P08236; -.
DR   TreeFam; TF300685; -.
DR   Reactome; R-HSA-2024096; HS-GAG degradation.
DR   Reactome; R-HSA-2160916; Hyaluronan uptake and degradation.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   ChiTaRS; GUSB; human.
DR   EvolutionaryTrace; P08236; -.
DR   GeneWiki; GUSB; -.
DR   GenomeRNAi; 2990; -.
DR   PRO; PR:P08236; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000169919; -.
DR   CleanEx; HS_GUSB; -.
DR   ExpressionAtlas; P08236; baseline and differential.
DR   Genevisible; P08236; HS.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0004566; F:beta-glucuronidase activity; IBA:GO_Central.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:AgBase.
DR   GO; GO:0005102; F:receptor binding; IPI:AgBase.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IBA:GO_Central.
DR   GO; GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome.
DR   GO; GO:0030214; P:hyaluronan catabolic process; TAS:Reactome.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   Gene3D; 2.60.120.260; -; 1.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR008979; Galactose-bd-like.
DR   InterPro; IPR006101; Glyco_hydro_2.
DR   InterPro; IPR023232; Glyco_hydro_2_AS.
DR   InterPro; IPR006103; Glyco_hydro_2_cat.
DR   InterPro; IPR023230; Glyco_hydro_2_CS.
DR   InterPro; IPR006102; Glyco_hydro_2_Ig-like.
DR   InterPro; IPR006104; Glyco_hydro_2_N.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   InterPro; IPR013783; Ig-like_fold.
DR   Pfam; PF00703; Glyco_hydro_2; 1.
DR   Pfam; PF02836; Glyco_hydro_2_C; 1.
DR   Pfam; PF02837; Glyco_hydro_2_N; 1.
DR   PRINTS; PR00132; GLHYDRLASE2.
DR   SUPFAM; SSF49303; SSF49303; 1.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF51445; SSF51445; 1.
DR   PROSITE; PS00719; GLYCOSYL_HYDROL_F2_1; 1.
DR   PROSITE; PS00608; GLYCOSYL_HYDROL_F2_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Glycoprotein;
KW   Glycosidase; Hydrolase; Lysosome; Mucopolysaccharidosis; Polymorphism;
KW   Reference proteome; Signal.
FT   SIGNAL        1     22       {ECO:0000269|PubMed:1311180}.
FT   CHAIN        23    651       Beta-glucuronidase.
FT                                /FTId=PRO_0000012161.
FT   ACT_SITE    451    451       Proton donor.
FT   CARBOHYD    173    173       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    272    272       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754519,
FT                                ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    420    420       N-linked (GlcNAc...) asparagine.
FT   CARBOHYD    631    631       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   VAR_SEQ     159    304       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054830.
FT   VAR_SEQ     305    355       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_001799.
FT   VARIANT      30     30       P -> S (in MPS7; dbSNP:rs747792546).
FT                                /FTId=VAR_058511.
FT   VARIANT      38     38       C -> G (in MPS7; very mild phenotype).
FT                                {ECO:0000269|PubMed:9490302}.
FT                                /FTId=VAR_037914.
FT   VARIANT      52     52       S -> F (in MPS7; loss of activity).
FT                                {ECO:0000269|PubMed:9099834}.
FT                                /FTId=VAR_037915.
FT   VARIANT     136    136       G -> R (in MPS7).
FT                                {ECO:0000269|PubMed:8644704}.
FT                                /FTId=VAR_037916.
FT   VARIANT     148    148       P -> S (in MPS7; dbSNP:rs121918177).
FT                                {ECO:0000269|PubMed:7633414}.
FT                                /FTId=VAR_037917.
FT   VARIANT     150    150       E -> K (in MPS7).
FT                                {ECO:0000269|PubMed:8644704}.
FT                                /FTId=VAR_037918.
FT   VARIANT     152    152       D -> G (in MPS7).
FT                                /FTId=VAR_058512.
FT   VARIANT     152    152       D -> N (functional polymorphism with no
FT                                clinical consequences; reduced activity
FT                                levels; dbSNP:rs149606212).
FT                                {ECO:0000269|PubMed:7573038,
FT                                ECO:0000269|PubMed:9490302}.
FT                                /FTId=VAR_037919.
FT   VARIANT     176    176       L -> F (in MPS7; dbSNP:rs121918181).
FT                                {ECO:0000269|PubMed:12859417,
FT                                ECO:0000269|PubMed:7573038,
FT                                ECO:0000269|PubMed:8089138,
FT                                ECO:0000269|PubMed:8644704}.
FT                                /FTId=VAR_037920.
FT   VARIANT     216    216       R -> W (in MPS7; dbSNP:rs121918174).
FT                                {ECO:0000269|PubMed:8111412,
FT                                ECO:0000269|PubMed:8644704}.
FT                                /FTId=VAR_003196.
FT   VARIANT     243    243       L -> P (in MPS7).
FT                                /FTId=VAR_058513.
FT   VARIANT     320    320       Y -> C (in MPS7).
FT                                {ECO:0000269|PubMed:8644704}.
FT                                /FTId=VAR_037921.
FT   VARIANT     320    320       Y -> S (in MPS7).
FT                                {ECO:0000269|PubMed:8644704}.
FT                                /FTId=VAR_037922.
FT   VARIANT     339    339       N -> S (in MPS7).
FT                                /FTId=VAR_058514.
FT   VARIANT     350    350       K -> N (in MPS7; dbSNP:rs121918182).
FT                                {ECO:0000269|PubMed:12522561}.
FT                                /FTId=VAR_037923.
FT   VARIANT     351    351       H -> Y (in MPS7; dbSNP:rs191153460).
FT                                {ECO:0000269|PubMed:8644704}.
FT                                /FTId=VAR_037924.
FT   VARIANT     354    354       A -> V (in MPS7; dbSNP:rs121918175).
FT                                {ECO:0000269|PubMed:8111413}.
FT                                /FTId=VAR_003197.
FT   VARIANT     361    369       Missing (in MPS7).
FT                                /FTId=VAR_058515.
FT   VARIANT     362    362       D -> N (in MPS7; dbSNP:rs398123234).
FT                                /FTId=VAR_058516.
FT   VARIANT     364    364       P -> L (in MPS7; dbSNP:rs771629102).
FT                                /FTId=VAR_058517.
FT   VARIANT     374    374       R -> C (in MPS7; dbSNP:rs747572640).
FT                                {ECO:0000269|PubMed:8644704}.
FT                                /FTId=VAR_037925.
FT   VARIANT     376    376       L -> F (in dbSNP:rs11559283).
FT                                /FTId=VAR_055884.
FT   VARIANT     382    382       R -> C (in MPS7; dbSNP:rs121918173).
FT                                {ECO:0000269|PubMed:1702266,
FT                                ECO:0000269|PubMed:8644704}.
FT                                /FTId=VAR_003198.
FT   VARIANT     382    382       R -> H (in MPS7).
FT                                {ECO:0000269|PubMed:8644704}.
FT                                /FTId=VAR_037926.
FT   VARIANT     408    408       P -> S (in MPS7; dbSNP:rs779091113).
FT                                {ECO:0000269|PubMed:8707294}.
FT                                /FTId=VAR_037927.
FT   VARIANT     415    415       P -> L (in MPS7; dbSNP:rs751025746).
FT                                {ECO:0000269|PubMed:8707294}.
FT                                /FTId=VAR_037928.
FT   VARIANT     435    435       R -> P (in MPS7).
FT                                {ECO:0000269|PubMed:8644704}.
FT                                /FTId=VAR_037929.
FT   VARIANT     477    477       R -> W (in MPS7; dbSNP:rs774393243).
FT                                {ECO:0000269|PubMed:8644704}.
FT                                /FTId=VAR_037930.
FT   VARIANT     495    495       Y -> C (in MPS7; dbSNP:rs121918178).
FT                                {ECO:0000269|PubMed:7633414}.
FT                                /FTId=VAR_037931.
FT   VARIANT     508    508       Y -> C (in MPS7).
FT                                {ECO:0000269|PubMed:8644704}.
FT                                /FTId=VAR_037932.
FT   VARIANT     540    540       E -> K (in MPS7).
FT                                /FTId=VAR_058518.
FT   VARIANT     572    572       G -> D (in MPS7).
FT                                {ECO:0000269|PubMed:8644704}.
FT                                /FTId=VAR_037933.
FT   VARIANT     577    577       R -> L (in MPS7; loss of activity;
FT                                dbSNP:rs121918183).
FT                                {ECO:0000269|PubMed:12522561}.
FT                                /FTId=VAR_037934.
FT   VARIANT     606    606       K -> N (in MPS7).
FT                                {ECO:0000269|PubMed:8644704}.
FT                                /FTId=VAR_037935.
FT   VARIANT     607    607       G -> A (in MPS7).
FT                                /FTId=VAR_058519.
FT   VARIANT     611    611       R -> W (in MPS7; dbSNP:rs121918176).
FT                                {ECO:0000269|PubMed:8111413}.
FT                                /FTId=VAR_003199.
FT   VARIANT     619    619       A -> V (in MPS7; dbSNP:rs121918172).
FT                                {ECO:0000269|PubMed:1702266}.
FT                                /FTId=VAR_003200.
FT   VARIANT     626    626       Y -> H (in MPS7; very mild phenotype;
FT                                dbSNP:rs777613366).
FT                                {ECO:0000269|PubMed:9490302}.
FT                                /FTId=VAR_037936.
FT   VARIANT     627    627       W -> C (in MPS7; dbSNP:rs121918184).
FT                                {ECO:0000269|PubMed:7680524,
FT                                ECO:0000269|PubMed:8644704}.
FT                                /FTId=VAR_003201.
FT   VARIANT     649    649       L -> P (in dbSNP:rs9530).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:3468507,
FT                                ECO:0000269|PubMed:8089138}.
FT                                /FTId=VAR_016179.
FT   STRAND       33     35       {ECO:0000244|PDB:1BHG}.
FT   STRAND       38     40       {ECO:0000244|PDB:3HN3}.
FT   STRAND       43     49       {ECO:0000244|PDB:3HN3}.
FT   STRAND       52     55       {ECO:0000244|PDB:1BHG}.
FT   HELIX        57     60       {ECO:0000244|PDB:3HN3}.
FT   HELIX        63     65       {ECO:0000244|PDB:3HN3}.
FT   HELIX        68     71       {ECO:0000244|PDB:3HN3}.
FT   STRAND       75     81       {ECO:0000244|PDB:3HN3}.
FT   TURN         84     86       {ECO:0000244|PDB:3HN3}.
FT   HELIX        90     93       {ECO:0000244|PDB:3HN3}.
FT   STRAND       97    105       {ECO:0000244|PDB:3HN3}.
FT   HELIX       109    113       {ECO:0000244|PDB:3HN3}.
FT   STRAND      117    124       {ECO:0000244|PDB:3HN3}.
FT   STRAND      128    134       {ECO:0000244|PDB:3HN3}.
FT   STRAND      137    147       {ECO:0000244|PDB:3HN3}.
FT   STRAND      149    152       {ECO:0000244|PDB:3HN3}.
FT   HELIX       154    157       {ECO:0000244|PDB:3HN3}.
FT   STRAND      166    173       {ECO:0000244|PDB:3HN3}.
FT   STRAND      180    182       {ECO:0000244|PDB:3HN3}.
FT   STRAND      185    188       {ECO:0000244|PDB:3HN3}.
FT   TURN        192    194       {ECO:0000244|PDB:3HN3}.
FT   STRAND      200    203       {ECO:0000244|PDB:3HN3}.
FT   STRAND      206    208       {ECO:0000244|PDB:3HN3}.
FT   STRAND      218    238       {ECO:0000244|PDB:3HN3}.
FT   STRAND      241    252       {ECO:0000244|PDB:3HN3}.
FT   STRAND      256    263       {ECO:0000244|PDB:3HN3}.
FT   STRAND      265    267       {ECO:0000244|PDB:1BHG}.
FT   STRAND      269    282       {ECO:0000244|PDB:3HN3}.
FT   TURN        291    293       {ECO:0000244|PDB:1BHG}.
FT   STRAND      294    296       {ECO:0000244|PDB:3HN3}.
FT   STRAND      301    311       {ECO:0000244|PDB:3HN3}.
FT   STRAND      314    324       {ECO:0000244|PDB:3HN3}.
FT   STRAND      329    331       {ECO:0000244|PDB:3HN3}.
FT   STRAND      336    338       {ECO:0000244|PDB:3HN3}.
FT   STRAND      341    343       {ECO:0000244|PDB:3HN3}.
FT   STRAND      345    349       {ECO:0000244|PDB:3HN3}.
FT   TURN        355    357       {ECO:0000244|PDB:3HN3}.
FT   HELIX       363    376       {ECO:0000244|PDB:3HN3}.
FT   STRAND      380    382       {ECO:0000244|PDB:3HN3}.
FT   HELIX       390    399       {ECO:0000244|PDB:3HN3}.
FT   STRAND      402    406       {ECO:0000244|PDB:3HN3}.
FT   HELIX       415    417       {ECO:0000244|PDB:3HN3}.
FT   HELIX       420    437       {ECO:0000244|PDB:3HN3}.
FT   STRAND      443    451       {ECO:0000244|PDB:3HN3}.
FT   HELIX       457    473       {ECO:0000244|PDB:3HN3}.
FT   STRAND      479    483       {ECO:0000244|PDB:3HN3}.
FT   TURN        487    489       {ECO:0000244|PDB:3HN3}.
FT   HELIX       493    495       {ECO:0000244|PDB:3HN3}.
FT   STRAND      497    502       {ECO:0000244|PDB:3HN3}.
FT   TURN        505    507       {ECO:0000244|PDB:3HN3}.
FT   STRAND      508    510       {ECO:0000244|PDB:3HN3}.
FT   HELIX       514    516       {ECO:0000244|PDB:3HN3}.
FT   HELIX       517    532       {ECO:0000244|PDB:3HN3}.
FT   STRAND      536    540       {ECO:0000244|PDB:3HN3}.
FT   HELIX       559    574       {ECO:0000244|PDB:3HN3}.
FT   TURN        575    580       {ECO:0000244|PDB:3HN3}.
FT   STRAND      581    587       {ECO:0000244|PDB:3HN3}.
FT   STRAND      600    604       {ECO:0000244|PDB:3HN3}.
FT   HELIX       617    631       {ECO:0000244|PDB:3HN3}.
SQ   SEQUENCE   651 AA;  74732 MW;  6BA7B1D935C9ABBD CRC64;
     MARGSAVAWA ALGPLLWGCA LGLQGGMLYP QESPSRECKE LDGLWSFRAD FSDNRRRGFE
     EQWYRRPLWE SGPTVDMPVP SSFNDISQDW RLRHFVGWVW YEREVILPER WTQDLRTRVV
     LRIGSAHSYA IVWVNGVDTL EHEGGYLPFE ADISNLVQVG PLPSRLRITI AINNTLTPTT
     LPPGTIQYLT DTSKYPKGYF VQNTYFDFFN YAGLQRSVLL YTTPTTYIDD ITVTTSVEQD
     SGLVNYQISV KGSNLFKLEV RLLDAENKVV ANGTGTQGQL KVPGVSLWWP YLMHERPAYL
     YSLEVQLTAQ TSLGPVSDFY TLPVGIRTVA VTKSQFLING KPFYFHGVNK HEDADIRGKG
     FDWPLLVKDF NLLRWLGANA FRTSHYPYAE EVMQMCDRYG IVVIDECPGV GLALPQFFNN
     VSLHHHMQVM EEVVRRDKNH PAVVMWSVAN EPASHLESAG YYLKMVIAHT KSLDPSRPVT
     FVSNSNYAAD KGAPYVDVIC LNSYYSWYHD YGHLELIQLQ LATQFENWYK KYQKPIIQSE
     YGAETIAGFH QDPPLMFTEE YQKSLLEQYH LGLDQKRRKY VVGELIWNFA DFMTEQSPTR
     VLGNKKGIFT RQRQPKSAAF LLRERYWKIA NETRYPHSVA KSQCLENSLF T
//
